microbiology, Vol 144, 3027-3037, Copyright © 1998 by Society for General Microbiology

ARTICLES

Immunization with recombinant class 1 outer-membrane protein from Neisseria meningitidis: influence of liposomes and adjuvants on antibody avidity, recognition of native protein and the induction of a bactericidal immune response against meningococci

M Christodoulides, JL Brooks, E Rattue and JE Heckels
Molecular Microbiology Group, University of Southampton Medical School, Southampton General Hospital, UK. mc4@soton.ac.uk

The porA gene from Neisseria meningitidis was cloned into the pRSETA vector and recombinant class 1 outer-membrane protein expressed at high levels in Escherichia coli. The protein was readily purified by affinity chromatography on a Ni2+ matrix and used for immunization of mice with conventional AI(OH)3 adjuvant, with experimental adjuvants which have the potential for human use, and with liposomes. The resulting sera were analysed for the magnitude, subclass distribution and antigenic specificity of the immune response. In addition, surface plasmon resonance (SPR) was used to quantify antibody avidity by analysis of the kinetics of binding to native class 1 protein. Immunization with conventional and experimental adjuvants induced antibodies of low avidity that did not recognize native class 1 protein. In contrast, immunization with recombinant protein in liposomes induced antibodies of high avidity which recognized native class 1 protein, as measured by their ability to label meningococcal cells in immunofluorescence assays and to inhibit the binding of a protective mAb. These properties were associated with the presence in sera of high levels of antibodies with the ability to induce complement- mediated killing of meningococci. These data show that liposomes containing recombinant class 1 protein represent a potential basis of future vaccines, of defined composition, designed for the prevention of group B meningococcal infections.

This article has been cited by other articles:

				D. Zhu, J. N. Williams, J. Rice, F. K. Stevenson, J. E. Heckels, and M. Christodoulides A DNA Fusion Vaccine Induces Bactericidal Antibodies to a Peptide Epitope from the PorA Porin of Neisseria meningitidis Infect. Immun., January 1, 2008; 76(1): 334 - 338. [Abstract] [Full Text] [PDF]

				J. N. Williams, P. J. Skipp, H. E. Humphries, M. Christodoulides, C. D. O'Connor, and J. E. Heckels Proteomic Analysis of Outer Membranes and Vesicles from Wild-Type Serogroup B Neisseria meningitidis and a Lipopolysaccharide-Deficient Mutant Infect. Immun., March 1, 2007; 75(3): 1364 - 1372. [Abstract] [Full Text] [PDF]

				G. A. Price, M. W. Russell, and C. N. Cornelissen Intranasal Administration of Recombinant Neisseria gonorrhoeae Transferrin Binding Proteins A and B Conjugated to the Cholera Toxin B Subunit Induces Systemic and Vaginal Antibodies in Mice Infect. Immun., July 1, 2005; 73(7): 3945 - 3953. [Abstract] [Full Text] [PDF]

				J. A. Welsch, R. Rossi, M. Comanducci, and D. M. Granoff Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine J. Immunol., May 1, 2004; 172(9): 5606 - 5615. [Abstract] [Full Text] [PDF]

				C. Arigita, L. Bevaart, L. A. Everse, G. A. Koning, W. E. Hennink, D. J. A. Crommelin, J. G. J. van de Winkel, M. J. van Vugt, G. F. A. Kersten, and W. Jiskoot Liposomal Meningococcal B Vaccination: Role of Dendritic Cell Targeting in the Development of a Protective Immune Response Infect. Immun., September 1, 2003; 71(9): 5210 - 5218. [Abstract] [Full Text] [PDF]

				J. C. Wright, J. N. Williams, M. Christodoulides, and J. E. Heckels Immunization with the Recombinant PorB Outer Membrane Protein Induces a Bactericidal Immune Response against Neisseria meningitidis Infect. Immun., August 1, 2002; 70(8): 4028 - 4034. [Abstract] [Full Text] [PDF]

				M. Christodoulides, B. L. Makepeace, K. A. Partridge, D. Kaur, M. I. Fowler, R. O. Weller, and J. E. Heckels Interaction of Neisseria meningitidis with Human Meningeal Cells Induces the Secretion of a Distinct Group of Chemotactic, Proinflammatory, and Growth-Factor Cytokines Infect. Immun., August 1, 2002; 70(8): 4035 - 4044. [Abstract] [Full Text] [PDF]

				D. M. Granoff, G. R. Moe, M. M. Giuliani, J. Adu-Bobie, L. Santini, B. Brunelli, F. Piccinetti, P. Zuno-Mitchell, S. S. Lee, P. Neri, et al. A Novel Mimetic Antigen Eliciting Protective Antibody to Neisseria meningitidis J. Immunol., December 1, 2001; 167(11): 6487 - 6496. [Abstract] [Full Text] [PDF]

				K. A. Jolley, L. Appleby, J. C. Wright, M. Christodoulides, and J. E. Heckels Immunization with Recombinant Opc Outer Membrane Protein from Neisseria meningitidis: Influence of Sequence Variation and Levels of Expression on the Bactericidal Immune Response against Meningococci Infect. Immun., June 1, 2001; 69(6): 3809 - 3816. [Abstract] [Full Text] [PDF]

				D. A. Haake, M. K. Mazel, A. M. McCoy, F. Milward, G. Chao, J. Matsunaga, and E. A. Wagar Leptospiral Outer Membrane Proteins OmpL1 and LipL41 Exhibit Synergistic Immunoprotection Infect. Immun., December 1, 1999; 67(12): 6572 - 6582. [Abstract] [Full Text] [PDF]

				G. R. Moe, S. Tan, and D. M. Granoff Differences in Surface Expression of NspA among Neisseria meningitidis Group B Strains Infect. Immun., November 1, 1999; 67(11): 5664 - 5675. [Abstract] [Full Text] [PDF]